Weight loss startup Calibrate raises $29M as part of private equity restructuring

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Cal­i­brate, the weight loss start­up that rose in pop­u­lar­i­ty with the rise of GLP-1 med­ica­tions on­ly to strug­gle to get pa­tients ac­cess to those med­ica­tions — lead­ing to pa­tient com­plaints and re­funds — has raised $29 mil­lion as part of its re­struc­tur­ing un­der a pri­vate eq­ui­ty in­vestor.

The new fund­ing, which was dis­closed in a Wednes­day fil­ing with the Se­cu­ri­ties and Ex­change Com­mis­sion, comes as Cal­i­brate goes through ma­jor changes to its busi­ness. In­sid­er in Oc­to­ber re­port­ed that the pri­vate eq­ui­ty firm Madryn As­set Man­age­ment is buy­ing Cal­i­brate. Cal­i­brate pre­vi­ous­ly told Mod­ern Health­care it was re­ceiv­ing cap­i­tal from Madryn and ex­ist­ing in­vestors.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.